Atlas Trials

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis

Clinical trial NCT05276011 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05276011
Sponsor
Kolon TissueGene, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Degenerative Osteoarthritis
Start date
2027-10-01
Primary completion
2028-10-01
Enrollment
255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.